Ampio Pharmaceuticals, Inc. announced that Dan Stokely has been appointed as Chief Financial Officer. Dan Stokely has more than 30 years of experience in finance and accounting and is a Certified Public Accountant. Dan began his career at Deloitte & Touche and since that time, he has spent the majority of his career in positions of financial leadership within both publicly traded and privately-held pharmaceutical companies.

Most recently, since 2012, Dan served as Executive Vice President and Chief Financial Officer of Sentynl Therapeutics. On July 10, 2019, the Company announced that Daniel Stokely will join the Company as Corporate Secretary, effective July 31, 2019.